Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

Koji Abe, Yasuto Itoyama, Gen Sobue et al. · 2014 · 360 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

Jesús S. Mora, Angela Genge, Adriano Chiò et al. · 2019 · 222 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Bulbar and speech motor assessment in ALS: Challenges and future directions

Jordan R. Green, Yana Yunusova, Mili Kuruvilla-Dugdale et al. · 2013 · 220 citations · Full text

Health Professions, Neurology, Speech-language Pathology +17

Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)

Sabrina Paganoni, Eric A. Macklin, Alexandra Lee et al. · 2014 · 214 citations · Full text

Medicine, Neurology, Diagnostic Assessment +12

Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders

Elaine Niven, Judith Newton, Jennifer A. Foley et al. · 2015 · 199 citations · Full text

Medicine, Neurology, Neuroscience +17